Journal of Clinical Epidemiology
Volume 55, Issue 4 , Pages 350-357 , April 2002

Assessing efficacy of chronic therapy when disease is characterized by frequent relapses: The example of schizophrenia

  • Alfredo Morabia

      Affiliations

    • Clinical Epidemiology Division, Geneva University Hospital, Geneva, Switzerland
    • Corresponding Author InformationCorresponding author. Clinical Epidemiology Division, University Hospital, Rue Micheli-du-Crest 25, 1211 Geneva 14, Switzerland. Tel: 41-22-37 29 552; fax: 41-22-37 29 565. E-mail address:
  • ,
  • Tom Ten Have

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  • ,
  • Philippe Huguelet

      Affiliations

    • Department of Psychiatry, Geneva University Hospital, Geneva, Switzerland
  • ,
  • François Ferrero

      Affiliations

    • Department of Psychiatry, Geneva University Hospital, Geneva, Switzerland

Received 26 February 2001 ,Revised 24 September 2001 ,Accepted 25 September 2001.

References 

  1. Robins JM, Greenland SM, Hu FB. Estimation of the causal effect of a time-varying exposure on the marginal mean of a repeated binary outcome. J Am Stat Assoc. 1999;94:687–712
  2. Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. New York: Oxford University Press;; 1994;
  3. Katz J, Carey VJ, Zeger SL, Sommer A. Estimation of design effects and diarrhea clustering within households and villages. Am J Epidemiol. 1993;138:994–1006
  4. Fitzmaurice GM, Laird NM, Zahner GE, Daskalakis C. Bivariate logistic regression analysis of childhood psychopathology ratings using multiple informants. Am J Epidemiol. 1995;142:1194–1203
  5. Zeger SL, Liang K-Y. Feedback models in discrete and continuous time series. Statistica Sinica. 1991;1:51–64
  6. Wing J, Cooper JE, Sartorius N. The description and classificaton of psychiatric symptoms (an instructional manual for the use of the PSE and Catego system). Cambridge: Cambridge University Press; 1974;
  7. Barrelet L, Ferrero F, Szigethy L, Giddey C, Pellizzer G. Expressed emotion and first-admission schizophrenia (nine-month follow-up in a French cultural environment). Br J Psychiatry. 1990;156:357–362
  8. Vaughn C, Leff J. The measurement of expressed emotion in the families of psychiatric patients. Br J Soc Clin Psychol. 1976;15:157–165
  9. Gunderson JG, Frank AF, Katz HM, Vannicelli ML, Frosch JP, Knapp PH. Effects of psychotherapy in schizophrenia (II. Comparative outcome of two forms of treatment). Schizophr Bull. 1984;10:564–598
  10. Ten Have T, Morabia A. An assessment of non-randomized medical treatment of long term schizophrenia relapse using bivariate response transition models. Biostatistics. 2002;3:press
  11. Ten Have T, Morabia A. Mixed effects models with bivariate and univariate association parameters for longitudinal bivariate binary response data. Biometrics. 1999;55:85–93
  12. Schwartz J. Air pollution and hospital admissions for the elderly in Birmingham, Alabama. Am J Epidemiol. 1994;139:589–598
  13. Johnson D, Freeman H. Long-acting tranquilizers. Practitioner. 1972;208:395–400
  14. Baldessarini RJ. In: Chemotherapy psychiatry (principles and practice). Cambridge: Harvard University Press;; 1985;p. 14–92
  15. Hu FB, Goldberg J, Hedeker D, Flay BR, Pentz MA. Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol. 1998;147:694–703
  16. Schooler NR. Maintenance medication for schizophrenia (strategies for dose reduction). Schizophr Bull. 1991;17:311–324

PII: S0895-4356(01)00483-8

Journal of Clinical Epidemiology
Volume 55, Issue 4 , Pages 350-357 , April 2002